Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer

1. Herzog, T.J.
2. Pignata, S.
3. Ghamande, S.A.
4. Rubio, M.-J.
5. Fujiwara, K.
6. Vulsteke, C.
7. Armstrong, D.K.
8. Sehouli, J.
9. Coleman, R.L.
10. Gabra, H.
11. Scambia, G.
12. Monk, B.J.
13. Arranz, J.A.
14. Ushijima, K.
15. Hanna, R.
16. Zamagni, C.
17. Wenham, R.M.
18. González-Martín, A.
19. Slomovitz, B.
20. Jia, Y.
21. Ramsay, L.
22. Tewari, K.S.
23. Weil, S.C.
24. Vergote, I.B.